FIELD: organic chemistry, medicine. SUBSTANCE: invention relates to potassium salts of different-ligand coordination compounds of magnesium with histidine and adenosine-5'-triphosphate of the formula (I) 
or with creatine phosphate of the formula (II) 
showing the protective effect on myocardium against ischemic damage. EFFECT: enhanced effectiveness of compounds. 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| INJECTIONAL FORM OF PREPARATION OF ANTIISCHEMIC ACTIVITY | 1999 |
|
RU2190411C2 |
| "INFUSOL" CARDIOPLEGIC SOLUTION | 2002 |
|
RU2226093C1 |
| CRYSTALLOID CARDIOPLEGIC SOLUTIONS, CONTAINING DODECAPEPTIDES (VERSIONS) | 2013 |
|
RU2549470C1 |
| METHOD TO TREAT ISCHEMIC CARDIAC DISEASE | 1994 |
|
RU2075963C1 |
| β-HYDROXY ETHYLAMINIUM NICOTINATE DERIVATIVES HAVING ANTIISCHENIC ACTIVITY | 1993 |
|
RU2124502C1 |
| METHOD OF SIMULATING ACUTE HEART ISCHEMIA | 0 |
|
SU1381397A1 |
| ANTIISCHEMICALLY-ACTIVE AGENT | 1988 |
|
RU2007985C1 |
| METHOD FOR PRESERVING MYOCARDIUM ACCOMPANYING TRANSPLANTATION | 2013 |
|
RU2535036C1 |
| METHOD OF DELIBERATE CARDIAC ARREST BEFORE AORTIC COMPRESSION IN CARDIAC SURGERIES EMPLOYING EXTRACORPOREAL CIRCULATION IN PATIENTS WITH AORTIC VALVE INCOMPETENCE | 2010 |
|
RU2432186C1 |
| METHOD OF PROPHYLAXIS AND TREATMENT OF PATIENT WITH MYOCARDIUM ISCHEMIA IN CORONARY-INVASIVE OPERATIONS | 1999 |
|
RU2146933C1 |
